JDRF Blog

JDRF Blog

Information on research, events, activities, and news from the T1D community across Canada. 

Subscribe to the newsletter

The Edmonton Protocol: JDRF celebrates 20th anniversary of first islet transplant

This month, twenty years ago, a pioneering clinical trial in Alberta marked a major advancement in islet transplantation for the treatment of type 1 d...

Read More

The 2019 Ontario Budget: How to turn disappointment into action

The 2019 Ontario Budget: How to turn disappointment into action

The results of the Ontario budget mean that your voice is now more important than ever. You can immediately support this initiative by writing, calling or meeting with your provincial or territorial representative by simply clicking here.


A JDRF legacy lives on with the Dr. Robert Goldstein Award

A JDRF legacy lives on with the Dr. Robert Goldstein Award

Dr. Esteban N. Gurzov, a talented young scientist from Brussels, Belgium, was recently named the first recipient of JDRF’s Dr. Robert Goldstein Award.


The impact of your story: How #AccessforAll is more successful when T1D stories are shared

The impact of your story: How #AccessforAll is more successful when T1D stories are shared

Having someone with the lived experience of diabetes relate their struggles with maintaining good blood glucose to political representatives and get across just how life-changing, in some cases life-saving, CGM and FGM devices can be, changes the whole conversation.


New Quebec registry tracks hypoglycemia among diabetes patients to help reduce risks

New Quebec registry tracks hypoglycemia among diabetes patients to help reduce risks

Dr. Rémi Rabasa-Lhoret, a JDRF-funded endocrinologist at the Institut de recherches cliniques de Montréal best known for his work on the artificial pancreas, is overseeing the initiative to collect data for the Quebec-wide registry of people with T1D in order to track the incidence of ...


Paying it forward through research: From trial participant to T1D advocate

Paying it forward through research: From trial participant to T1D advocate

From Walk participant to trial participant to T1D advocate, here is Ash Hunkin's story.


JDRF Canada welcomes new Chief Scientific Officer, Dr. Sarah Linklater

JDRF Canada welcomes new Chief Scientific Officer, Dr. Sarah Linklater

We are pleased to announce Dr. Sarah Linklater has been appointed as Chief Scientific Officer (CSO). 


New test offers better insight into genetic risk of type 1 diabetes in people of African descent

New test offers better insight into genetic risk of type 1 diabetes in people of African descent

Recently, a team of researchers in the United States developed a test to identify individuals of African descent who are more likely to get the disease.


Studying the role of Vitamin D in the risk of type 1 diabetes

Studying the role of Vitamin D in the risk of type 1 diabetes

Does Vitamin D play a role in developing type 1 diabetes (T1D)?


Sernova recruits first subjects for its Cell Pouch<sup>TM</sup> diabetes clinical trial

Sernova recruits first subjects for its Cell Pouch diabetes clinical trial

Since 2016, JDRF and Sernova Corp., a clinical-stage regenerative medicine company, have been collaborating on innovative technology to treat hypoglycaemia (low sugar) unawareness in patients with severe T1D.


Lets turn type one into type none